Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice

Physiological Genomics

Volumn 1999, Issue 1, 1999, Pages 3-9

  Davisson, Robin L ^a   Ding, Yueming ^a   Stec, David E ^a   Catterall, James F ^b   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Angiotensin II; Blood pressure regulation; Renal function; Transgenic mice

Indexed keywords

MUS MUSCULUS;

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; LOSARTAN; MESSENGER RNA;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD PRESSURE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENE TARGETING; GENETICS; HUMAN; HYPERTENSION; KIDNEY; METABOLISM; MOUSE; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE;

ANGIOTENSINOGEN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GENE TARGETING; HUMANS; HYPERTENSION; KIDNEY; LOSARTAN; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 0033564984     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.1999.1.1.3     Document Type: Article

References (31)

1. Braam, B., K. D. Mitchell, J. Fox, and L. G. Navar. Proximal tubular secretion of angiotensin II in rats. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F891-F898, 1993.
2. Brunner, H. R., H. Gavras, and A. Waeber. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann. Intern. Med. 2: 1317-1325, 1979.
3. Cogan, M. G. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458, 1990.
4. Cowley, A. W. J., and R. J. Roman. The role of the kidney in hypertension. JAMA 275: 1581-1589, 1996.
5. Davisson, R. L., G. Yang, T. G. Beltz, M. D. Cassell, A. K. Johnson, and C. D. Sigmund. The brain renin-angiotensin system contributes to the hypertension exhibited by mice containing both human renin and human angiotensinogen transgenes. Circ. Res. 83: 1047-1058, 1998.
6. Ding, Y., R. L. Davisson, D. O. Hardy, L.-J. Zhu, D. C. Merrill, J. F. Catterall, and C. D. Sigmund. The kidney androgen-regulated protein (KAP) promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J. Biol. Chem. 272: 28142-28148, 1997.
7. Douglas, J. G., M. Romero, and U. Hopfer. Signaling mechanisms coupled to the angiotensin receptor of proximal tubular epithelium. Kidney Int. 30: S43-S47, 1990.
8. Dzau, V. J. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77: I4-I13, 1988.
9. Fukamizu, A., K Sugimura, E. Takimoto, F. Sugiyama, M.-S. Seo, S. Takahashi, T. Hatae, N. Kajiwara, K. Yagami, and K. Murakami. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. Biol. Chem. 268: 11617-11621, 1993.
10. Gimenez-Roqueplo, A. P., J. Celerier, G. Lucarelli, P. Corvol, and X. Jeunemaitre. Role of N-glycosylation in human angiotensinogen. J. Biol. Chem. 273: 21232-21238, 1998.
11. Hatae, T., E. Takimoto, K. Murakami, and A. Fukamizu. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol. Cell. Biochem. 131: 43-47, 1994.
12. Hopkins, P. N., R. P. Lifton, N. K. Hollenberg, X. Jeunemaitre, M. C. Hallouin, J. Skuppin, C. S. Williams, R. G. Dluhy, J. M. Lalouel, R. R. Williams, and G. H. Williams. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J. Hypertens. 14: 199-207, 1996.
13. Ingelfinger, J. R., W. M. Zuo, E. A. Fon, K. E. Ellison, and V. J. Dzau. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J. Clin. Invest. 85: 417-423, 1990.
14. Inoue, I., T. Nakajima, C. S. Williams, J. Quackenbush, R. Puryear, M. Powers, T. Cheng, E. H. Ludwig, A. M. Sharma, A. Hata, X. Jeunemaitre, and J. M. Lalouel. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99: 1786-1797, 1997.
15. Jeunemaitre, X., F. Soubrier, Y. V. Kotelevtsev, R. P. Lifton, C. S. Williams, A. Charru, S. C. Hunt, P. N. Hopkins, R. R. Williams, J.-M. Lalouel, and P. Corvol. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992.
16. Junggren, I. L., X. Zhao, X. Sun, and T. Hedner. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat. J. Pharm. Pharmacol. 48: 829-833, 1996.
17. Levens, N. R., M. J. Peach, and R. M. Carey. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ. Res. 48: 157-167, 1981.
18. Merrill, D. C., M. W. Thompson, C. Carney, G. Schlager, J. E. Robillard, and C. D. Sigmund. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J. Clin. Invest. 97: 1047-1055, 1996.
19. Meseguer, A., and J. F. Catterall. Androgen regulated expression of kidney androgen-regulated protein mRNAis localized in the epithelial cells of the murine renal proximal convoluted tubules. Mol. Endocrinol. 1: 535-541, 1987.
20. Meseguer, A., and J. F. Catterall. Cell-specific expression of kidney androgen-regulated protein messenger RNA is under multihormonal control. Mol. Endocrinol. 4: 1240-1248, 1990.
21. Morgan, T., C. Craven, L. Nelson, J. M. Lalouel, and K. Ward. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J. Clin. Invest. 100: 1406-1415, 1997.
22. Navar, L. G., J. D. Imig, and C. T. Wang. Intrarenal production of angiotensin II. Semin. Nephrol. 17: 412-422, 1997.
23. Redgrave, J., S. Rabinowe, N. K. Hollenberg, and G. H. Williams. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J. Clin. Invest. 75: 1285-1290, 1985.
24. + exchange in proximal tubule cells. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F1188-F1195, 1990.
25. Schunkert, H., J. R. Ingelfinger, A. T. Hirsch, S. S. Tang, S. E. Litwin, C. E. Talsness, and V. J. Dzau. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J. Clin. Invest. 90: 1523-1529, 1992.
26. Shimkets, R. A., D. G. Warnock, C. M. Bositis, C. Nelson-Williams, J. H. Hansson, M. Schambelan, J. R. Gill, S. Ulick, R. V. Milora, J. W. Findling, C. M. Canessa, B. C. Rossier, and R. P. Lifton. Liddle's syndrome: heritable human hypertension caused by mutations in the subunit of the epithelial sodium channel. Cell 79: 407-414, 1994.
27. Sigmund, C. D., C. A. Jones, C. M. Kane, C. Wu, J. A. Lang, and K. W. Gross. Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ. Res. 70: 1070-1079, 1992.
28. Simon, D. B., C. Nelson-Williams, M. J. Bia, D. Ellison, F. E. Karet, A. M. Molina, I. Vaara, F. Iwata, H. M. Cushner, M. Koolen, F. J. Gainza, H. J. Gitleman, and R. P. Lifton. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12: 24-30, 1996.
29. Siragy, H. M., N. L. Howell, M. J. Peach, and R. M. Carey. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F522-F529,1990.
30. Ward, K., A. Hata, X. Jeunemaitre, C. Helin, L. Nelson, C. Namikawa, P. F. Farrington, M. Ogasawara, K. Suzumori, S. Tomoda, S. Berrebi, M. Sasaki, P. Corvol, R. P. Lifton, and J.-M. Lalouel. A molecular variant of angiotensinogen associated with preeclampsia. Nat. Genet. 4: 59-61, 1993.
31. Yang, G., D. C. Merrill, M. W. Thompson, J. E. Robillard, and C. D. Sigmund. Functional expression of the human angiotensinogen gene in transgenic mice. J. Biol. Chem. 269: 32497-32502, 1994.